Skip Nav Destination
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
Red Cells, Iron, and Erythropoiesis
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease
PLENARY PAPER
Red Cells, Iron, and Erythropoiesis
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea
Camila Bononi Almeida,Lucas Eduardo Botelho Souza,Flavia Costa Leonardo,Fabio Trindade Maranhão Costa,Claudio C. Werneck,Dimas Tadeu Covas,Fernando Ferreira Costa,Nicola Conran
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12
Clinical Trials & Observations
John Kuruvilla,David A. MacDonald,C. Tom Kouroukis,Matthew Cheung,Harold J. Olney,A. Robert Turner,Peter Anglin,Matthew Seftel,Walid Sabry Ismail,Stefano Luminari,Stephen Couban,Tara Baetz,Ralph M. Meyer,Annette E. Hay,Lois Shepherd,Marina S. Djurfeldt,Sameer Alamoudi,Bingshu E. Chen,Michael Crump
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
Clinical Trials & Observations
Michael L. Wang,Kristie A. Blum,Peter Martin,Andre Goy,Rebecca Auer,Brad S. Kahl,Wojciech Jurczak,Ranjana H. Advani,Jorge E. Romaguera,Michael E. Williams,Jacqueline C. Barrientos,Ewa Chmielowska,John Radford,Stephan Stilgenbauer,Martin Dreyling,Wieslaw Wiktor Jedrzejczak,Peter Johnson,Stephen E. Spurgeon,Liang Zhang,Linda Baher,Mei Cheng,Dana Lee,Darrin M. Beaupre,Simon Rule
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
Clinical Trials & Observations
Dae-Young Kim,Young-Don Joo,Sung-Nam Lim,Sung-Doo Kim,Jung-Hee Lee,Je-Hwan Lee,Dong Hwan (Dennis) Kim,Kihyun Kim,Chul Won Jung,Inho Kim,Sung-Soo Yoon,Seonyang Park,Jae-Sook Ahn,Deok-Hwan Yang,Je-Jung Lee,Ho-Sup Lee,Yang Soo Kim,Yeung-Chul Mun,Hawk Kim,Jae Hoo Park,Joon Ho Moon,Sang Kyun Sohn,Sang Min Lee,Won Sik Lee,Kyoung Ha Kim,Jong-Ho Won,Myung Soo Hyun,Jinny Park,Jae Hoon Lee,Ho-Jin Shin,Joo-Seop Chung,Hyewon Lee,Hyeon-Seok Eom,Gyeong Won Lee,Young-Uk Cho,Seongsoo Jang,Chan-Jeoung Park,Hyun-Sook Chi,Kyoo-Hyung Lee,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology,for the Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology
IMMUNOBIOLOGY
A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy
Amélie Bonaud,Sébastien Bender,Guy Touchard,Corinne Lacombe,Nivine Srour,Laurent Delpy,Christelle Oblet,Anne Druilhe,Nathalie Quellard,Vincent Javaugue,Michel Cogné,Frank Bridoux,Christophe Sirac
LYMPHOID NEOPLASIA
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner,Hon-Wah Man,Celia Fontanillo,Maria Wang,Suzana Couto,Mike Breider,Chad Bjorklund,Courtney G. Havens,Gang Lu,Emily Rychak,Heather Raymon,Rama Krishna Narla,Leo Barnes,Gody Khambatta,Hsiling Chiu,Jolanta Kosek,Jian Kang,Michael D. Amantangelo,Michelle Waldman,Antonia Lopez-Girona,Ti Cai,Michael Pourdehnad,Matthew Trotter,Thomas O. Daniel,Peter H. Schafer,Anke Klippel,Anjan Thakurta,Rajesh Chopra,Anita K. Gandhi
MYELOID NEOPLASIA
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib
Clinical Trials & Observations
Keyur P. Patel,Kate J. Newberry,Rajyalakshmi Luthra,Elias Jabbour,Sherry Pierce,Jorge Cortes,Rajesh Singh,Meenakshi Mehrotra,Mark J. Routbort,Madan Luthra,Taghi Manshouri,Fabio P. Santos,Hagop Kantarjian,Srdan Verstovsek
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
BLOOD WORK
-
Cover Image
Cover Image
Platelet-forming cells of the mouse embryo appear in 2 waves, first as a primitive diploid population in the yolk sac, followed by polyploid megakaryocytes in the fetal liver. To investigate their emergence and dispersal throughout development, the whole embryonic day 10.5 embryo was stained and chemically cleared to reveal platelet-forming cells within the vasculature. See the article by Potts et al on page 807.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals